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The spontaneous  modulation  of granulomatous  inflammation  in chronic murine 
schistosomiasis represents  a  naturally occurring immune process that leads to dimin- 
ished T  cell-mediated  inflammatory responses around parasite ova in the tissues  (1- 
4). A recent series of studies has shown that this spontaneous modulation is associated 
with  the  appearance  of  regulatory  T  cells  (5-11)  that  can  adoptively  suppress 
granuloma  formation  in  vivo  and  lymphokine  production  in  vitro  (5,  6).  One 
population  was  active  in  the  long-term  adoptive  suppression  of acutely  infected 
recipients  and expressed  the  Lyt-l+,2-,3-,Ia  + phenotype  (6,  9),  and  another caused 
short-term suppression  of responses in uninfected recipients  and was defined as Lyt- 
1-,2  +, 3 + (11). Because lymphoeytes of mice undergoing modulation had an impaired 
capacity to produce migration  inhibition  factor  (MIF) 1 and  eosinophil  stimulation 
promoter  (ESP)  -active  lymphokines  (3,  4)  that  are  presumed  to  function  in  the 
formation  of the  granuloma  (12-14),  we postulated  that  modulation  of the  granu- 
lomatous response is carried out  by regulatory suppressor T  (Ts)  cells  that  suppress 
lymphokine  production  by  lymphokine  secretor  T  (TDH)  cells.  This  postulate  was 
confirmed by demonstrating that spleens of chronically infected mice contained Lyt- 
1-,2+,3 +, I-J+/I-C  + Ts cells that  suppress  in  ~,itro  MIF production  by Lyt-l+,2-,3 -, 
Ia- TDH cells of acutely infected animals  (8). 
The  present  study  was  undertaken  to  further  examine  mechanisms  by  which 
inflammatory  and  suppressor  T  cell  subpopulations  interact  in  the  modulation  of 
granuloma formation. We specifically wished to examine the mechanism(s)  by which 
Lyt-l-,2+,3 +  Ts  cells  suppress  the  production  of  MIF.  Our  results  suggest  that 
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suppression of lymphokine secretion is mediated by a soluble suppressor factor (MIF- 
SF).  MIF-SF appears  to  belong to  a  new family of I-C antigen bearing suppressor 
factors first described to function in the MLR system (t5). Initial characterization of 
MIF-SF showed that its production involves Lyt 1-,2+,3  + T  cells, it is antigen specific, 
acting only on soluble schistosome egg antigen (SEA)  -primed cells, and minimally 
requires I-AB or I-C compatibility with target ceils to exert its effect. Thus, at  least 
under in vitro conditions, I-C-encoded suppressor  factors  may act  as signals in the 
regulation of lymphokine secretion by Lyt  1+2  .  3- effector Tz~H. 
Materials and Methods 
Animals and Infection.  Female, CBA/J (H-2  k) mice obtained from The Jackson Laboratory, 
Bar Harbor, ME were used in all experiments. In those experiments comparing strain responses, 
BALB/c (H-2  d) and C57BL/6 (H-2 b) mice were kindly provided by Dr. Y. M. Kong and Dr. 
H.  C.  Rauch, respectively.  All other strains were  acquired from colonies maintained at  the 
Mayo Medical School, Rochester, MN. Mice were maintained under standard laboratory care 
and provided with food and water ad lib. 7-8-wk-old CBA mice were infected subcutaneously 
with 25 cercariae of the Puerto Rican strain of Schistosoma mansoni. 
Preparation of SEA.  SEA were prepared from homogenized eggs isolated from the livers of 
infected mice (16). 
Preparation of MIF-SF.  Spleen cells of 20-wk infected CBA mice were harvested aseptically 
and suspended to 1 ×  107 nucleated cells/ml of RPMI 1640 containing 2 rnM glutamine, 100 
U/ml penicillin  and 100 ~g/ml streptomycin (Grand Island Biological Co., Grand Island, NY), 
and 1 p.g/ml SEA. 2-ml aliquots of the suspensions were distributed into 16 ×  125-mm tissue 
culture tubes (BioQuest; Falcon Labware, Becton, Dickinson & Co.,  Oxnard, CA) and incu- 
bated at 37°C for 90 rain in a humidified 5% CO2 atmosphere. After this pulse with SEA, the 
cells were centrifuged and washed twice in prewarmed unsupplemented medium. Finally, the 
cells were  resuspended in 2 ml of RPMI  1640 supplemented with antibiotics and  10% heat- 
inactivated normal  human  serum  (RPMI-NHS)  (Grand  Island  Biological  Co.)  that  was 
absorbed with 1:5 volume of a mixture of mouse spleen and peripheral blood cells (30 rain at 
room temperature) before use. The cells were cultured for 24 h, then centrifuged at 500 g for 10 
min. Supernatants were then collected from above the cell pellet and stored at -70°C. Control 
supernatants were obtained from SEA-pulsed normal spleen cells. 
Assays for Suppression of MIFActivity.  Mineral oil-induced peritoneal cells were obtained from 
SEA-Freund's complete adjuvant (FCA)-sensitized mice (SPEC)  as  described previously (8). 
SPEC gave consistent migration inhibition  in the presence of 0.5-10/*g/ml SEA or 5-10/,g/ml 
purified  protein  derivative  (PPD)  (Parke,  Davis  and  Co.,  Detroit,  MI).  To  tes~ antigen 
specificity,  PEC were also obtained from mice sensitized with 30 big crystallized bovine serum 
albumin (BSA) (Sigma Chemical Co.,  St. Louis, MO) in FCA. Such SPEC were inhibited in 
the presence of 10-20/*g/mI BSA or 5- I0 btg/mi PPD, but were unaffected by SEA. Spleen cell 
supernatants of 20-wk infected mice (20-wk SP) to be tested for suppressor activity were diluted 
in fresh RPMI-NHS then supplemented with 1 #g/ml SEA. The standard capillary migration 
inhibition assay  was  performed  using SPEC  with  dilutions of  20-wk  SP  supernatants as 
incubation medium. Conditions of the MIF assay and methods of measuring migration areas 
have  been  described  in  detail  (8). If the  expected  migration inhibition was  significantly 
abrogated, then it was concluded that suppressor factor was present in the test supernatant. 
In some experiments, 20-wk SP were tested for the capacity to suppress SEA-elicited MIF 
production by cultured spleen cells  of 8-wk  infected mice  (8-wk  SP).  The latter cells  were 
cultured for 24 h  in the presence of serially diluted putative suppressor factor supplemented 
with 1/*g/ml SEA. After incubation, the culture supernates were tested for MIF activity using 
normal peritoneal exudate cells (NPEC) as previously described (8). 
Antisera and Complement Treatments. Anti-Thy-1.2 serum was prepared by multiple immuniza- 
tions of AKR mice with CBA thymocytes; this preparation was  highly specific  for  CBA T 
lymphocytes.  Anti-Lyt-l.1  and  anti-Lyt-2.1  were  generously provided  by  Dr.  F.-W.  Shen 
(Memorial Sloan-Kettering  Cancer Center, New York). Anti-l(ABJ)  k [A.BY X B 10.HTT) anti- CHENSUE,  BOROS, AND  DAVID  221 
A.TL],  anti-I (EC)kk [B10.S(7R)  anti-B10.HTT], anti-I(JE)  k  [(B10.B2  ×  A.BY)  anti-B10.A 
(5R)], and anti-I-C  [A ×  B 10) anti-B  10.AM] sera were prepared at the Mayo Medical School. 
Rabbit serum absorbed with mouse tissues (Accurate Chemicals Inc., Westbury, NY) served as 
a source  of complement. Antisera and complement were used for cytolysis  as follows:  Spleen 
cells (1 ×  107/ml) were incubated for 30 min at 4°C in antiserum diluted in RPMI 1640 (anti- 
Thy-l.2,  1:10;  anti-Lyt-l.1,  1:100,  anti-Lyt-2.1,  1:50). Control  serum  consisted  of normal 
(BALB/c ×  C57BL/6)F1 serum. After incubation, cells were washed by centrifugation at 4°C, 
suspended to their original volume in a  1  : 10 dilution of complement, then incubated for 30 
min at 37°C. After incubation,  cells were washed three times, their viability was determined by 
dye exclusion, and cell concentrations were adjusted according to numbers of live cells. 
Preparation and  Use of Insoluble Immunoabsorbents.  Immunoabsorbents were  prepared  as  de- 
scribed by Rich et al. (15). Heat inactivated sera were dialyzed for 18 h against coupling buffer 
(0.1 M NaHCO3, 0.5 M NaCI, pH 8.0). A volume of 1.0 ml of serum was mixed with a 2.5-ml 
bed volume of cyanogen bromide-activated Sepharose 4B beads (Pharmacia Fine Chemicals, 
Div. of Pharmacia Inc., Piscataway, N  J) in a sealed silieonized glass tube and gently rotated 
overnight at 4°C. Unbound protein was removed by washing with coupling buffer, then the 
beads were  suspended in 1 M  ethanolamine (pH 8.0) and rotated for an additional 1.5 h  to 
block any remaining active sites. Using a sintered glass filter, the coupled beads were washed 
with three alternating cycles of 0.1 M acetate buffer (pH 4.0) and 0.1 M borate buffer (pH 8.0) 
both containing 1 M NaCI. The material was next washed with 100 ml of phosphate-buffered 
saline (PBS)  pH 7.2) and then mixed with 4.0 ml of a  3% BSA solution in 0.05  M  Tris-HC1 
(pH 7.6) and incubated for 1 h at 4°C to block nonspecific binding  sites. After incubation, the 
bed was washed extensively with PBS and excess fluid was removed. 4 ml of culture supernatant 
was then added to the bed. This mixture was returned to a sealed glass tube and gently rocked 
for 2 h at 4°C. After rocking, the slurry was transferred to a 0.7 X 12-cm plastic columns with 
a  sintered glass  base and the adsorbed supernatant was drawn off using negative pressure. 
Virtually all the applied supernatant was recovered by this method with minimal dilution. 
After rinsing the immunoabsorbent with PBS, bound suppressor material was recovered by 
adding 4 ml of cold glycine-HCl buffer (pH 2.8) and incubating  the mixture for 15 min at 4°C. 
The glycine eluate was drawn off then dialyzed against RPMI for 24 h.  Before  testing, the 
dialyzed eluate was mixed with an equal volume of RPMI-NHS having twice the concentration 
of supplementary ingredients. 
Statistical Methods.  The Student's t test was used to determine significant differences between 
migration areas of control and experimental groups. Values of P >  0.05 were considered not 
significant. Percent migration inhibition was calculated as follows: [(migration area of control 
-  migration area  of experimental)/(migration area  of control)]  ×  100. Inhibitions of ~20 
percent represented significant differences  in migration areas. The degree of suppression was 
calculated as follows:  ](percent inhibition of control -  percent inhibition of experimental)/ 
(percent inhibition of control)] ×  100. 
Results 
Demonstration of MIF-SF in the Culture Supernates  of 20-wk SP.  We previously showed 
that 20-wk SP can directly suppress SEA-induced MIF production by both 8-wk SP 
and SPEC ofsyngeneic mice (8). To determine whether this suppression was mediated 
by soluble suppressor  factor(s),  we  examined supernatant from  20-wk  SP  in both 
indirect and direct MIF assays. Using the indirect assay, 8-wk SP were cultured for 24 
h  in the presence of SEA and serially diluted supernatants from 20-wk SP or normal 
spleen  cells  (NSP).  The  culture  supernatant  were  subsequently assayed  for  MIF 
activity.  As  shown  in  Fig.  1,  supernatants of 20-wk  SP  strongly suppressed  MIF 
production by 8-wk SP  as compared with controls. Significant suppressive activity 
was  present  even  at  1:8  dilution of supernatant.  At  high  concentration, normal 
supernatant also showed moderate suppressive activity. This may be explained by the 
presence  of small  amounts of suppressor  factor  produced  by  SEA-pulsed  normal 222  I-C  SUBREGION  FACTOR  SUPPRESSES  LYMPHOKINE  PRODUCTION 
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Fro.  1.  The suppresive effect of 20-wk SP supernatants on MIF production of SEA-stimulated 8- 
wk SP cultures. 8-wk SP were cultured in the presence of serial dilutions of suppressor (0) or control 
(O) supernatants supplemented with 1 ~g/ml SEA. At 24 h, the culture supernatants were collected 
and assayed for MIF activity using NPEC as indicator cells. The 0-point baseline consisted of a  1:2 
dilution ofsupernatant of NSP not pulsed with SEA. Points indicate mean +  SE of seven individual 
8-wk supernatant preparations. 
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Fro.  2.  The suppressive effect  of 20-wk  SP supernatants on  the SEA-elicited MIF-response of 
SPEC.  Suppressor supernatants were serially diluted with fresh medium, then supplemented to  1 
#g/ml SEA before injection into assay chambers. Control is a  1:2 dilution of supernatant of NSP 
pulsed with SEA. Bars represent the mean _+ SE of two to three separate experiments. 
spleen  cells.  Spleen  cells  unpulsed  by  SEA  showed  no  activity  (Fig.  1,  0  point).  We 
next tested the suppressive activity of supernates  in the direct MIF  assay using SPEC 
as  indicator  cells  (Fig.  2).  At  a  1:2  or  1:3  dilution,  20-wk  SP  supernatant  clearly 
suppressed  the  MIF  activity  of  SEA-stimulated  SPEC.  However,  suppression  was 
usually  lost at  a  1:4 dilution of supernatant.  Note that  in this system normal  control 
supernatants  showed  no  suppression  even  at  a  1:2  dilution.  For  the sake  of its  ease 
and  rapidity, the direct assay was used for all of our subsequent  analyses. CHENSUE,  BOROS, AND DAVID  223 
Examination of  the  dose-response  kinetics  of  MIF-SF  production  showed  that 
greatest  suppressive activity was obtained in cultures where  20-wk  SP  were briefly 
pulsed with  0.I  and  1.0  #g/ml  of SEA.  It  is  of note  that  detectable activity was 
produced even in the absence of exogenous antigenic stimulation (Table I). By direct 
assay, it was also demonstrated that the suppressive activity (MIF-SF) was nondialyz- 
able, indicating that it has a  molecular weight of >  12,000 (data not shown). 
Characterization of the  Cells Involved in  the Production of MIF-SF.  Having previously 
shown that Lyt-l-,2+,3  +, T  cells of 20-wk SP suppressed MIF production (8), it was 
of interest to determine whether the same subset of cells was involved in the production 
of MIF-SF. To answer this question, 20-wk SP were pretreated with Thy-1 and Lyt 
antigen-specific alloantisera and complement, then cultured and assayed for MIF-SF 
production.  Fig.  3  shows  that  MIF-SF  activity  was  eliminated  by  anti-Thy-l.2 
treatment, indicating a  role for T  cells. Furthermore, the subset of T  cells involved 
appeared to be Lyt-l-,2+,3  ÷, because anti-Lyt-2.1, but not anti-Lyt-1.1, could elimi- 
TABLE  I 
Antigen Dose-Response of MIF-SF Factor Production 
Dose of SEA to  Migration 
elicit  inhibition:~  Suppression 
MIF-SF* 
#g/ml  %  % 
Control  28.5 + 3.7  -- 
0  17.3 + 3.3  39 
0.1  3.6 + 25.7  87 
1.0  2.3 +  12.8  92 
10.0  17.7 + 5.7  38 
* Spleen cells of 20-wk SP mice were pulsed for 90 min with graded doses of 
SEA then washed and cultured for 24 h. Supernatants were then collected 
and assayed against SPEC. 
:~ Value represent mean migration inhibition + SD derived from two separate 
experiments. Each experiment was performed in duplicate. 
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FIG. 3.  Characterization of  the surface phenotype of  cells  involved in MIF-SF production. 20-wk 
SP were pretreated with the indicated alloantisera and complement, washed, then cultured for the 
production of MIF-SF as described in Materials and Methods. Bars represent mean +- SE of three 
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nate  activity.  In  fact,  supernatants  of anti-Lyt-2.1  pretreated  20-wk  SP  augmented 
rather than suppressed the migration inhibition of SPEC. 
Antigen and H-2 Specificity  of MIF-SF.  Antigen specificity of MIF-SF was examined 
directly using SPEC from SEA-FCA or BSA-FCA-sensitized  mice. As Fig. 4 illustrates, 
MIF-SF  suppressed MIF  activity elicited by either SEA or  PPD,  using SPEC  from 
SEA-FCA immunized mice. However, the factor was inactive when tested in a  system 
that lacked schistosome specificity. Thus MIF-SF did not suppress either the BSA- or 
PPD-elicited migration  inhibition using  SPEC  of BSA-FCA-sensitized mice.  These 
results indicate the antigen-specific nature of MIF-SF. 
When CBA (H-2  k) MIF-SF was tested on SPEC from a  battery of histoincompatible 
and H-2-recombinant strains, a  clear H-2 specificity was revealed (Table II). MIF-SF 
had no significant effect upon the lymphocytes of incompatible mice such as BALB/ 
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Fro.  4.  Demonstration of antigen specificity of MIF-SF. Suppressor (glt) and control (rn) superna- 
tants were diluted with an equal volume of fresh medium, then supplemented with 1/xg/ml SEA, 
5 #g/ml PPD, or 10/~g/ml  BSA before transfer into MIF assay chambers. Bars represent mean + 
SE of three separate experiments. 
TABLE  II 
Genetic Requirement  for Suppressor Function of MIF-SF 
H-2  Percent migration inhibition 
Strain*  1 #g  10/.tg 
KABJ  ECS  GD 
CON  MIF-SF  CON  MIF-SF 
Mean per- 
cent sup- 
pression 
CBA/J  k  k  k  k  k  k  k  k  k  43.9  16.7  46.9  29.3  49.8 
BALB/c  d  d  d  d  d  d  d  d  d  33.6  44.3  53.3  48.7  4.3 
C57BL/6  b  b  b  b  b  b  b  b  b  27.6  22.9  35.7  29.7  17.0 
B10.BR  k  k  k  k  k  k  k  k  k  26.5  16.6  51.1  17.5  51.6 
B10.A  k  k  k  k  k  d  d  d  d  54.2  t3.l  35.8  16.6  64.7 
A/Sn  k  k  k  k  k  d  d  d  d  --~:  --  46.2  15,4  66.0 
C3H.OL  d  d  d  d  d  d  k  k  k  37.5  30,3  38,5  42.9  9,6 
C3H.OH  d  d  d  d  d  d  d  d  k  --:~  --  24.5  21.2  13.5 
BI0.AQR  q  k  k  k  k  d  d  d  d  38.0  16.9  34.3  2.5  74.1 
BI0.S(9R)  s  s  s  k  k  d  d  d  d  --~  --  31.2  28.1  9.9 
B10.HTT  s  s  s  s  k  k  k  k  d  31.5  9.2  50.3  33.4  52.2 
* SPEC  from  five  to  six  mice of each  strain  were  pooled  and  tested in  duplicate  or  triplicate with 
supernatants of normal (CON) or 20-wk SP (MIF-SF) cultures.  MIF chambers contained 1:3 dilutions of 
supernatant supplemented to 1 /tg/ml or 10 ~g/ml SEA. 
:~ Less than 20% migration inhibition achieved with 1/~g SEA. CHENSUE,  BOROS,  AND  DAVID  225 
c  (H-2  d)  and  C57BL/6  (H-2~.  However,  strong  activity  was  seen  with  B10.BR 
(H-2k), which shares only H-2 genes with CBA, arguing against  the involvement of 
non-H-2 gene products. Further analysis revealed a significant suppression with B 10.A 
and A/Sn, but not with C3H.OL and C3H.OH strains. These results suggested that 
K and I region genes but not S, G, and D genes determined susceptibility to MIF-SF. 
A more detailed examination showed that suppression could be obtained with I-ABJE 
(B10.AQR)  or I-EC, SG  (BI0.HTT) but  not  with  I-JE  [B10.SOR)]  compatibility. 
Taken together, our findings suggest that LAB or I-C subregion compatibility is the 
minimal requirement for target cell susceptibility to MIF-SF. 
Expression of I  Region-encoded Antigens by MIF-SF.  Because the activity of MIF-SF 
appeared  to be H-2 restricted, we wished  to determine if this factor carried major 
histocompatibility complex (MHC)-encoded antigens.  Specifically, we tested for the 
presence of I  region-associated  antigens,  which  have been  found  in  other soluble 
mediators of suppression  (15,  17-22).  To this end, insoluble immunoabsorbent col- 
umns  were prepared with  various  bound  alloantisera  directed against  I  subregion 
determinants. Samples of MIF-SF active supernatants were absorbed as described in 
Materials and Methods and tested for suppressor activity. Table III shows the result 
of these experiments. Suppressor activity was not removed by normal mouse serum 
(NMS),  anti-(ABJ) k,  or anti-0E) k,  but  was  completely eliminated with  anti-(EC) k 
and anti-C  k alloantisera. Because only the columns with anti-I-C antibodies were able 
to adsorb the suppressor activity, it appeared that I-C subregion determinants were 
expressed by MIF-SF. 
To further substantiate  these findings and eliminate the possibility that  MIF-SF 
was simply inactivated by the column adsorption, we next attempted to recover the 
column-bound MIF-SF by elution with glycine-buffer at low pH. After elution, the 
material  was  dialyzed against  fresh medium,  restored to  its  original  volume,  then 
tested for suppressor activity. As shown in Fig. 5, MIF-SF was recovered from both 
the anti-(EC) k and C k columns, whereas no activity was found on the NMS column. 
Discussion 
The spontaneous modulation  of granulomatous  hypersensitivity in  experimental 
schistosomiasis mansoni provides a  unique model for the analysis of natural mecha- 
nisms that regulate chronic, cell-mediated inflammations. In previous studies (3-I 1), 
TABLE  III 
Expression of I-C Subregion Determinants by MIF-SF 
Supernatant  Column adsorption*  Migration inhibition~-  Suppression 
Normal 
20-wk 
%  % 
None  23.1 :tz 3.3  -- 
NMS  11.3 ±  2.9  51.0 
Anti-I(ABJ)  k  6.5 ±  7.1  71.9 
Anti-I(EC)  k  30.6 ±  4.9  0 
Anti-l(JE) k  4.8 ±  12.8  79.2 
Anti-IC  k  26.2 zt: 6.0  0 
* 20-wk SP supernatants were adsorbed with solid-phase immunoadsorbents as described in Materials and 
Methods. 
:~ Values represent mean ±  SE of three separate experiments, using three different 20-wk  SP supernatant 
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FIG.  5.  Suppressive effect  of acid  eluates from anti-I subregion immunoadsorbents. Immunoad- 
sorbents that had bound MIF-SF were treated with glycine buffer (pit 2.8) to elute bound material. 
Eluent material was dialyzed against fresh medium, reconstituted with antibiotics and serum, then 
tested for suppressive activity.  Control:  migration inhibition in presence of eluate from the NMS 
column, which did  not remove suppressor activity,  Dotted line shows baseline inhibition in a  1:2 
dilution of NSP supernatant. Bars represent means of two separate experiments. 
the involvement of suppressor T  cells in the modulation of granuloma formation and 
lymphokine  production  was  delineated.  Numerous  observations  indicate  that  the 
modulated granulomatous response is the result of a dynamic equilibrium maintained 
between effector (TDH) and suppressor (Ts) cells.  (a) The granulomatous response is 
diminished,  but  not  abrogated,  during  the  process of modulation  (3,  4).  (b)  Mice 
displaying  modulation  regain  their  vigorous  granulomatous  response  and/or  the 
capacity to produce MIF after the elimination of Ts lymphocytes by cyclophospha- 
mide (7, 9) or anti-I-J subregion alloantiserum  (10).  (c) Splenic lymphocytes of mice 
undergoing  modulation  are  capable  of transferring  accelerated granulomatous  re- 
sponse to naive recipients  (11).  (d)  Cotransfer of equal  numbers of splenic T  ceils 
from acutely and chronically infected mice suppresses granuloma formation in na'ive 
recipients (11).  (e) The Lyt-1-,2+,3  +, I-C+/I-J + subset of Ts lymphocytes from spleens 
of chronically infected mice admixed with Lyt 1  +, Ia- TDH cells suppressed in vitro 
the production of MIF by the latter (8). Because an association between inflammatory 
lymphokines  and  the  schistosome  egg-induced  granulomatous  response  has  been 
established (12-14), regulation of lymphokine production would be a likely mode for 
the maintenance of diminished granulomatous inflammatory responses. 
The present study was designed to further elucidate the mechanism(s) of interaction 
between  effector  and  suppressor  lymphocytes  that  occurs  during  the  modulated 
granulomatous response.  Results show that  splenic lymphocytes of mice displaying 
modulation secrete or shed into the culture fluid a soluble factor that can suppress in 
vitro the production of MIF. The factor, whose production involves the Lyt- 1-,2+,3 + 
subset  of splenic T  cells,  can replace in concentrated or dilute  ferm the suppressor 
activity of live Ts cells. Though MIF-SF is also produced by unstimulated splenocytes, 
the in vitro production of the factor seems to be antigen dependent. This observation 
may bear relevance to in vivo conditions. In chronically infected mice, higher antigen 
concentrations may prevail  in  the modulated often less  cellular granulomas.  Thus, 
strong  Iocal  antigenic  stimuli  emanating  from  the  parasite  ova could  induce  and CHENSUE, BOROS, AND DAVID  227 
sustain the production of MIF-SF by Ia  + T cells that infiltrate the immunomodulated 
lesions (6). 
In repeated experiments, MIF-SF inhibited lymphokine production in the SEA and 
in the unrelated tuberculin immune systems. However, inhibition occurred only when 
SEA and tuberculin-sensitive lymphocytes were present together. In the absence of 
the  SEA-specific component, MIF-SF  was  ineffective in  either the  BSA-  or FCA- 
primed  systems. Based on this we assume,  that  MIF-SF bears specificity for SEA- 
sensitive, H-2-compatible target ceU(s).  Interaction between factor and target cell(s) 
causes the release of a  nonspecific factor(s)  that  suppresses mediator production in 
heterologous  cell-mediated  systems  as  well.  This  assumption  concurs  with  recent 
reports  (23,  24)  that  describe the  participation  of antigen-specific and  nonspecific 
components in cell-mediated systems that are regulated by various Ts cell-initiated 
pathways.  We  previously  observed  (6)  that  Ts  cells  adoptively  transferred  from 
immunomodulated donors did not suppress heterologous granulomas in the lungs of 
recipients.  In  the light  of present observations, this is explicable if we postulate as 
prerequisites for suppression (a) the specific triggering by MIF-SF of local granuloma 
lymphocytes, and  (b)  the short range, intralesional effect of the released nonspecific 
immunoregulatory products. 
Suppression  of TDa  function  by  MIF-SF  was  H-2  restricted.  More  specifically, 
effective interaction required I-AB or I-C region compatibility of the target cell with 
the source of factor. Further analysis by immunoabsorption indicated that  MIF-SF 
expressed I-C subregion-encoded determinants. Thus, MIF-SF seems to belong to the 
group of genetically restricted, immunoregulatory molecules that derive from I region 
genes (15,  17-22).  Some of these molecules expresses I-J, others I-C specificities. To 
date, IoC antigen-bearing (I-C  +) suppressor factors have been shown to regulate mixed 
leukocyte reaction (MLR)  (15) and contact sensitivity (22). Our present observations 
extend their involvement to the regulation of inflammatory lymphokine production 
during a  chronic granulomatous  disease.  It  is  noteworthy that  MIF-SF differed in 
genetic requirement from the suppressor factor active in contact sensitivity. Restriction 
of the latter was determined by the K  and  D  regions of the MHC. This difference 
may  reflect  the  nature  of the  antigen  and  its  particular  mode  of presentation. 
Moorhead  (22)  has shown that  the acceptor molecules for the suppressor factor of 
contact  sensitivity are  hapten°modified  H-2K and/or  D  alloantigens.  In  contrast, 
soluble protein/glycoprotein antigens such as SEA are likely to be presented with I 
region-encoded determinants (25).  However, further genetic analysis and delineation 
of molecular targets will be necessary to precisely define the relationship of MIF-SF 
to the MHC. 
Presently, MIF-SF most closely resembles the factor that suppressed cell prolifera- 
tion  in  the  MLR  (MLR-TsF).  This  factor was  I-C  subregion  restricted,  antigen 
nonspecific, did not bind foreign antigens, and required I-J+/I-C + Lyt 2  + T  cells for 
its production (15, 24). Though we have not directly shown that MIF-SF production 
involves I-J+/I-C ÷ Ts cells, this would be expected as such cells were required for the 
suppression of MIF production in recent in vitro admixture experiments (8). 
Based on this previous observation, detection of both I-J  + and  I-C  + factors were 
predicted. Experiments showed, however, the presence only of an I-C  + factor. Various 
explanations  may  be  offered  for  this  discrepancy.  A  simple  one  would  be  the 
insensitivity of the fairly crude bioassay (abrogation of migration inhibition), which 228  I-C SUBREGION FACTOR SUPPRESSES LYMPHOKINE PRODUCTION 
could not detect very small amounts of I-J  + materials. A  more plausible assumption 
would assert that I-J  + factors went undetected  because they do not interact directly 
with  TDH  target  cells.  This  is  an  attractive  explanation,  in  the  light  of  recent 
observations showing that long-term in vivo administration of anti-I-J alloantiserum 
to schistosome infected mice abrogated the onset of modulation of the granulomatous 
response (10). Thus, conceivably I-J  + factors may participate in the specific recruit- 
ment  and  activation of suppressor precursor lymphocytes (9),  whereas  I-C  + factors 
would  maintain  the  modulated  inflammatory  response  via  the  regulation  of lym- 
phokine production.  The demonstration  that I-J  + factors participate in the recruit- 
ment of suppressor populations that regulate humoral (26) and cell-mediated responses 
(19,  20)  lends further weight to these speculations. 
In summary, in the present study we extended previous observations and showed 
that in vitro lymphokine production is regulated by soluble I subregion gene products 
derived from Lyt  1-,2+,3 + Ts lymphocytes. Though the final target of this factor is 
the TDH effector cell, an indirect interaction between MIF-SF and such a cell via an 
intermediary T  cell (24) or macrophage (27)  is not excluded. The in vivo relevance of 
such a  suppressor factor in the process of modulation of the granulomatous response 
is under current investigation. 
Summary 
In the present study, we extended the analysis of the regulation of inflammatory 
lymphokine production in mice with schistosomiasis mansoni. Splenic lymphocytes of 
chronically infected mice were briefly pulsed in vitro by soluble egg antigens, washed, 
and  then  cultured  overnight.  The  supernatant  culture  fluid  added  to  cultures  of 
splenic cells of acutely infected or peritoneal lymphocytes of antigen-sensitized mice 
inhibited  the production  of migration  inhibition  factor (MIF).  Elaboration  of MIF 
suppressor factor (MIF-SF) required the Lyt-l-,2+,3  + subset of T  lymphocytes. MIF- 
SF acted only on egg antigen-primed cells and required  H-2 compatibility with the 
target cell for its suppressive effect. Further analysis with recombinant strains revealed 
that the factor interacted with LAB or I-C subregion-compatible target cells. Exper- 
iments  using  immunoadsorbent  columns  with  bound  anti-I  subregion  alloantisera 
indicated that MIF-SF contained I-C subregion-encoded determinants. Extrapolation 
of this in  vitro model to in  vivo conditions would  indicate  that  the granulomatous 
response is modulated by I region-derived suppressor factor(s) that regulate lympho- 
kine production by TBn effector cells. 
Received for publication  1 September 1982. 
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